Liberia

in page functions
[French]
Total population (2016) 4,615,221
Birth cohort (2016) 158,427
Surviving Infants (surviving to 1 year per year, 2016) 149,743
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 53/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 70/1000
World Bank Index, IDA (2012) 2.92
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 15

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Liberia

Type of support

Approvals

2001-2020 (US$)
(25 Aug 2016)

Commitments

2001-2020 (US$)
(25 Aug 2016)

Disbursements

2000-2016 (US$)
(25 Aug 2016)

% Disbursed

(25 Aug 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cash Support (CASHSUPP) $198,500 $223,500 $198,500 100%
Ebola EPI Recovery Plan (EEPIRP) $2,811,269 $2,811,269 $2,811,269 100%
Health system strengthening (HSS 1) $3,689,254 $3,689,254 $3,689,254 100%
Health system strengthening (HSS 2) $4,680,000 $4,680,000 $3,240,000 69%
HPV Demo (NVS) $299,607 $299,607 $234,348 78%
Immunisation services support (ISS) $2,188,750 $2,188,750 $2,188,750 100%
Injection safety support (INS) $360,500 $360,500 $266,500 74%
IPV (NVS) $326,193 $428,193 $13,410 4%
Penta (NVS) $10,488,808 $10,488,808 $11,308,989 108%
Pneumo (NVS) $6,727,008 $6,727,008 $7,856,100 117%
Rotavirus (NVS) $1,010,941 $1,010,941 $1,010,941 100%
Vaccine Introduction Grant (VIG) $619,000 $619,000 $619,000 100%
Yellow Fever (NVS) $1,923,808 $1,923,808 $2,033,948 106%
Total $35,323,639 $35,450,639 $35,471,009

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Liberia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 65%
M:F sex ratio at birth (2016) 1.05
Household survey: DTP3 coverage for male (2012) 69.20%
Household survey: DTP3 coverage for female (2012) 73.80%
Household survey: Last DTP3 survey (2012) 71%
% districts achieving > 80% DTP3 coverage (2015) 20%
% districts achieving < 50% DTP3 coverage (2015) 7%
MCV WHO/UNICEF estimates (2015) 64%

Breakdown of support

Non-vaccine support Vaccine support
37% 63%
$13,013,273 $22,457,733

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Liberia

19 September 2016

Stockpiling

On the frontline: Gavi’s support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

17 August 2016

Ebola: Redemption Hospital, Monrovia

Ebola contact tracer: life on the frontline

Emmanuel Lasanah, outpatient supervisor at Monrovia’s Redemption Hospital, became one of the lead contact tracers during the recent Ebola outbreak, tracking down more than 900 potentially infected people. Given his high-risk status, he was also the first person in Liberia to receive the new vaccine against Ebola.

08 August 2016

Liberia, two years on: President Ellen Johnson Sirleaf discusses the Ebola outbreak

President Ellen Johnson Sirleaf describes Ebola’s impact on Liberia, and the steps taken to rebuild the country's health system.

close icon

modal window here